MedPath
NMPA Approval

Compound Paracetamol and Chlorphenamine Maleate Granules

国药准字H13023263

October 18, 2020

国药准字H13023263

Drug Information

复方氨酚那敏颗粒

颗粒剂

复方

化学药品

October 18, 2020

Company Information

Applicant Company

南宫市腾飞路55号

Manufacturing Company

南宫市腾飞路55号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

复方氨酚那敏颗粒 - NMPA 批准文号 | MedPath